fda semaglutide Receives Approval for Treatment of MASH FDA Gives Ozempic New Side

Clinical studies have shown that Tesamorelin significantly reduces abdominal fat, particularly in individuals with obesity or HIV-associated lipodystrophy

Whereas, for example, in Germany, even when youre obese, you still need certain other comorbidities in addition to the obesity to even get a prescription of these drugs

FDAs Pharmaceutical Compounding Advisory Committee voted to add six of seven peptides to the 503A Bulk Drug Substance List, despite FDA scientists recommending against all of them because of limited evidence of their safety and effectiveness

Challenges in bariatric surgery: outcomes in patients having three or more bariatric procedures